David Arkowitz
CFO
CFO
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President, Chief Financial Officer and Head of Business Development | $470,900 | $1,786,650 |
| 2021 | Seres Therapeutics, Inc. (MCRB) | Executive Vice President, Chief Financial Officer and Head of Business Development | $265,417 | $5,226,695 |
Executive changes
Earnings-call appearances
-
Seres Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-05
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-02
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-08
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2023 Earnings Call2023-04-27
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-07
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-02
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-03
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-04
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-01
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Seres Therapeutics, Inc. (MCRB)
-
Seres Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-03
Seres Therapeutics, Inc. (MCRB)
-
Pacira BioSciences, Inc. Q1 FY2021 Earnings Call2021-05-04
Pacira BioSciences, Inc. (PCRX)